AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇰🇪
Emicizumab in Kenya
4 products registered with PPB — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Hemlibra 150mg/1ml. Solution For Injection | H2022/CTD10352/21731 | F. Hoffmann-La Roche Ltd, | active | 11 Apr 2028 |
| Hemlibra 60mg/ 0.4ml Solution For Injection | H2022/CTD10353/21729 | F. Hoffmann-La Roche Ltd | active | 11 Apr 2028 |
| Hemlibra 30mg/ml. Solution For Injection | H2022/CTD10354/21728 | F. Hoffmann-La Roche Ltd | active | 11 Apr 2028 |
| Hemlibra 105 mg/0.7 ml. Solution For Injection | H2022/CTD10355/21730 | F. Hoffmann-La Roche Ltd, | active | 11 Apr 2028 |
Emicizumab — PPB Registration Details
PPB (Kenya) has 4 registered products containing Emicizumab, of which 4 are currently active. Data is sourced directly from the official PPB drug register and refreshed daily.
Track Emicizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.